On the HCPLive news page, resources on the topics of disease- and specialty-specific medical news and expert insight can be found. Content includes articles, interviews, videos, podcasts, and breaking news on health care research, treatment, and drug development.
Chronic Low Back Pain: Pregabalin Helps Reduce Pain and Sleep Interference
A new study suggests that pregabalin shows significantly greater improvements in pain-related interference of sleep relative to usual care in patients with chronic low back pain with accompanying neuropathic pain (CLBP-NeP).
Predicting Fracture Risk in Patients with Osteoporosis
In 2014, the fracture risk algorithm FRAX celebrated its 20-year anniversary. Developed by a World Health Organization (WHO) study group in 1994, FRAX is a freely available diagnostic tool used to evaluate the 10-year probability of bone fracture risk, mostly for patients with osteoporosis. It is a part of many national health guidelines worldwide.
Patients with the cystic fibrosis transmembrane conductance regulator gating mutation G551D have insufficient ion transport due to reduced channel-open probability. New information suggests that increased ion transport reduces disease burden in the pancreas, which prevents cystic fibrosis patients from digesting food properly and leads to exocrine pancreatic insufficiency in up to 90% of all cases.
New Treatment Option for Severe Depression Has Fewer Side Effects
August 13th 2015Australian research indicates that ultra-brief pulse stimulation is nearly as effective as standard electroconvulsive therapy (ECT) for the treatment of severe depression, but with substantially fewer cognitive side effects.
Bacteria Band Together to Fight Infection
August 12th 2015In a recent study, researchers assessed seven groups of mice that were given various antibiotics and then exposed to C. diff spores. Using advanced genetic analysis, the team determined which bacteria survived the antibiotic challenge, as well as what factors allowed C. diff to effectively infect the mice.
Impact of Genetic Variations on Schizophrenia Treatment Effectiveness
Safe, effective treatments for schizophrenia are well-established in the United States and worldwide, with several second-generation antipsychotics (SGAs) approved for use. But earlier schizophrenia studies have shown that several single nucleotide polymorphisms (SNPs) – the genetic variations that can underlie differences in susceptibility to disease – are overexpressed in Caucasian patients with schizophrenia but not in their Chinese counterparts, and vice versa.
Study Will Evaluate Bipolar Medication in Treating Borderline Personality Disorder
Borderline personality disorder (BPD) is challenging to diagnose and treat. As yet, there are no drugs currently licensed for BPD treatment. In fact, guidance from England's National Institute for Health and Care Excellence recommends that pharmacologic therapy not be used for patients with BPD at all. This is potentially troubling, because those patients typically experience rapid and extreme changes in mood, poor social functioning and have high rates of suicidal behavior.
Q&A With Paul Doghramji: Shift Work Disorder and the Future of Sleep Medicine
For some people their best time to work is when others are usually asleep. For these patients and others with sleep disorders finding the right treatment can be difficult, especially when it comes to medications.
Plasma Exchange May Be Effective Treatment for CRPS
Complex regional pain syndrome (CRPS) is one of the pain conditions that has remained fairly mysterious, but a new, effective treatment may be on the horizon. It is known that CRPS most often develops following trauma, however, and evidence suggests a maladaptive response to nervous system damage involving immune and inflammatory pathways as well as abnormalities in both peripheral and central processing of afferent inputs. No single therapy – including pharmacologic therapy – wholly addresses the condition.
Self-Management for Patients Suffering from Depression
Self-management for chronic or long-term conditions such as pain, diabetes, asthma, or arthritis is now a common part of long-term care. The same is not true for depression. At least, not yet. As clinicians learn more about depression, it has ceased to be viewed alongside other acute conditions and is now often thought of as chronic or long-term. Research shows that more than half of all people will have at least one further depressive episode after their first.
DMARD-Free Sustained Remission in Rheumatoid Arthritis with Early and Intense Treatment
Rheumatoid arthritis therapy that focuses on early and more intensive treatment produces DMARD-free sustained remission, according to findings from researchers at the Karolinska Institutet.
New Research Could Widen Nasal Spray Flu Vaccine Age
August 11th 2015The current nasal spray flu vaccine on the market is not approved for all age groups – so what's another option for those excluded individuals besides the flu shot? Researchers may have found a way to broaden the range on the nasal spray.
Two Extra Minutes for Medication Safety?
As the population ages and medicine continues to advance, people are living longer and healthier; but they are also taking more medications for more medical conditions. Those medications can cause drug-drug interactions that lead to adverse drug reactions (ADR). Studies have shown that the majority of medication errors happen at the stage of prescription.
Q&A With Paul Doghramji: Diagnosing and Treating Excessive Sleepiness and Sleep Apnea
A growing term in the healthcare field is excessive sleepiness. What does it mean and how can it affect a patient's life are explained in this segment of our interview with Paul Doghramji, MD.
Q&A With Paul Doghramji: An Introduction to Sleep Disorders and the Role of Primary Care Physicians
Primary care physicians see a wide range of patients with any number of symptoms. In light of this it can be easy for simple things like sleep disorders to slip through the cracks which can be harmful to the patient's overall health.
Tumor Necrosis Factor Inhibitors and NAFLD
August 11th 2015Nonalcoholic fatty liver disease (NAFLD) is now the most common chronic liver disease reported in the United States. Some researchers have hypothesized that TNF-α, as a mediator of inflammation, might be a therapeutic target for NAFLD since inflammation seems to be a component of its etiology.
Coming Soon: Flu Vaccination Without the Use of Needles
August 11th 2015Japanese research suggests that influenza vaccination using a dissolving microneedle patch made of hyaluronic acid appears to be promising for practical use as an easy and effective method to replace conventional injection systems.